Kwaku P Asante

Summary

Publications

  1. ncbi Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial
    Kwaku Poku Asante
    Kintampo Health Research Centre, Kintampo, Ghana
    Lancet Infect Dis 11:741-9. 2011
  2. ncbi Malaria epidemiology in the Ahafo area of Ghana
    Kwaku P Asante
    Kintampo Health Research Centre, Ghana Health Service, Ministry of Health, P O Box 200, Kintampo, Ghana
    Malar J 10:211. 2011
  3. ncbi Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana
    Dominic B Dery
    Kintampo Health Research Centre, Ghana Health Service, Ministry of Health, Kintampo, Ghana
    Malar J 9:314. 2010
  4. ncbi Epidemiology of malaria in the forest-savanna transitional zone of Ghana
    Seth Owusu-Agyei
    Kintampo Health Research Centre, Kintampo, Ghana
    Malar J 8:220. 2009
  5. ncbi Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy
    Kwaku P Asante
    Kintampo Health Research Centre, Ghana Health Service, PO Box 200, Kintampo, Ghana
    BMC Public Health 10:409. 2010
  6. ncbi Trends in multiplicity of Plasmodium falciparum infections among asymptomatic residents in the middle belt of Ghana
    Akua Agyeman-Budu
    Kintampo Health Research Centre, Ghana Health Service, Ministry of Health, Kintampo, Ghana
    Malar J 12:22. 2013

Collaborators

Detail Information

Publications6

  1. ncbi Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial
    Kwaku Poku Asante
    Kintampo Health Research Centre, Kintampo, Ghana
    Lancet Infect Dis 11:741-9. 2011
    ..8 month follow-up data have been reported for safety and immunogenicity of RTS,S/AS01(E) when integrated into the EPI. We report extended follow-up to 19 months, including efficacy results...
  2. ncbi Malaria epidemiology in the Ahafo area of Ghana
    Kwaku P Asante
    Kintampo Health Research Centre, Ghana Health Service, Ministry of Health, P O Box 200, Kintampo, Ghana
    Malar J 10:211. 2011
    ..Newmont Ghana Gold Limited is conducting mining activities in the Brong Ahafo Region of Ghana that may have an impact on the diseases such as malaria in the mining area...
  3. ncbi Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana
    Dominic B Dery
    Kintampo Health Research Centre, Ghana Health Service, Ministry of Health, Kintampo, Ghana
    Malar J 9:314. 2010
    ..Therefore, entomological surveys were carried out in the forest-savannah transitional belt of Ghana (Kintampo) from November 2003 to November 2005 in preparation for drug and vaccine trials...
  4. ncbi Epidemiology of malaria in the forest-savanna transitional zone of Ghana
    Seth Owusu-Agyei
    Kintampo Health Research Centre, Kintampo, Ghana
    Malar J 8:220. 2009
    ..As a background to the establishment of a site for anti-malarial drugs and vaccine trials, the epidemiology of malaria in a rural site in central Ghana was investigated...
  5. ncbi Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy
    Kwaku P Asante
    Kintampo Health Research Centre, Ghana Health Service, PO Box 200, Kintampo, Ghana
    BMC Public Health 10:409. 2010
    ..We report the perceptions of malaria and malaria treatment behaviour, the community awareness of and perceptions about AS-AQ two years after the introduction of this ACT treatment for malaria...
  6. ncbi Trends in multiplicity of Plasmodium falciparum infections among asymptomatic residents in the middle belt of Ghana
    Akua Agyeman-Budu
    Kintampo Health Research Centre, Ghana Health Service, Ministry of Health, Kintampo, Ghana
    Malar J 12:22. 2013
    ....